In a previous investigation, our data indicated that MAGI2-AS3 exhibited reduced expression in breast cancer, and it was capable of inhibiting the progression of breast cancer (Du et al., 2019; Yang et al., 2018). Here, MAGI2 is linked to breast carcinoma.